Nu Skin Enterprises Stock Buy Hold or Sell Recommendation
| NUS Stock | USD 6.45 0.03 0.46% |
Considering the 90-day investment horizon and your conservative attitude towards risk, our recommendation regarding Nu Skin Enterprises is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Nu Skin Enterprises given historical horizon and risk tolerance towards Nu Skin. When Macroaxis issues a 'buy' or 'sell' recommendation for Nu Skin Enterprises, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Nu Skin Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as NUS and provide practical buy, sell, or hold advice based on investors' constraints. Nu Skin Enterprises. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
NUS |
Execute Nu Skin Buy or Sell Advice
The NUS recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nu Skin Enterprises. Macroaxis does not own or have any residual interests in Nu Skin Enterprises or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nu Skin's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Nu Skin Trading Alerts and Improvement Suggestions
| Nu Skin Enterprises generated a negative expected return over the last 90 days | |
| Nu Skin Enterprises has high historical volatility and very poor performance | |
| Over 82.0% of the company shares are owned by institutional investors | |
| On 11th of September 2024 Nu Skin paid $ 0.06 per share dividend to its current shareholders | |
| Latest headline from zacks.com: Nu Skin Enterprises Lags Q3 Earnings and Revenue Estimates |
Nu Skin Returns Distribution Density
The distribution of Nu Skin's historical returns is an attempt to chart the uncertainty of Nu Skin's future price movements. The chart of the probability distribution of Nu Skin daily returns describes the distribution of returns around its average expected value. We use Nu Skin Enterprises price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nu Skin returns is essential to provide solid investment advice for Nu Skin.
| Mean Return | -0.67 | Value At Risk | -7.86 | Potential Upside | 4.10 | Standard Deviation | 3.27 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nu Skin historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
NUS Stock Institutional Investors
The Nu Skin's institutional investors refer to entities that pool money to purchase Nu Skin's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Bank Of New York Mellon Corp | 2024-06-30 | 901.1 K | Aristotle Capital Boston, Llc | 2024-06-30 | 768.4 K | American Century Companies Inc | 2024-06-30 | 565.1 K | Amvescap Plc. | 2024-06-30 | 543.4 K | Millennium Management Llc | 2024-06-30 | 534.6 K | Goldman Sachs Group Inc | 2024-06-30 | 532.3 K | Northern Trust Corp | 2024-06-30 | 511.9 K | Norges Bank | 2024-06-30 | 506.6 K | Proshare Advisors Llc | 2024-06-30 | 505.6 K | Blackrock Inc | 2024-06-30 | 8.1 M | Vanguard Group Inc | 2024-06-30 | 6.5 M |
Nu Skin Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 18.4M | (31.1M) | (95.3M) | 40.3M | (13.2M) | (13.9M) | |
| Change In Cash | (51.3M) | 67.1M | (63.1M) | (74.9M) | (8.7M) | (8.2M) | |
| Free Cash Flow | 111.9M | 315.3M | 73.0M | 49.0M | 60.1M | 57.1M | |
| Depreciation | 76.7M | 74.0M | 76.3M | 72.5M | 69.6M | 47.6M | |
| Dividends Paid | 82.2M | 78.4M | 76.3M | 77.0M | 77.6M | 54.2M | |
| Capital Expenditures | 66.1M | 63.8M | 68.6M | 59.1M | 58.5M | 52.5M | |
| Net Income | 173.6M | 191.4M | 147.3M | 104.8M | 8.6M | 8.2M | |
| End Period Cash Flow | 335.6M | 402.7M | 339.6M | 264.7M | 256.1M | 248.8M | |
| Other Non Cash Items | 48.3M | 49.1M | 82.6M | 62.7M | 124.6M | 130.8M | |
| Change Receivables | 2.7M | (11.2M) | 20.2M | (11.4M) | (13.2M) | (12.5M) | |
| Net Borrowings | (69.5M) | (27.5M) | 40M | 22.4M | 20.2M | 14.3M | |
| Change To Netincome | 15.7M | 15.1M | 81.0M | (21.1M) | (24.2M) | (23.0M) | |
| Investments | 2.7M | (656K) | (1.1M) | (8.0M) | (132.5M) | (125.9M) |
Nu Skin Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nu Skin or Personal Care Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nu Skin's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a NUS stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.8 | |
β | Beta against Dow Jones | 0.70 | |
σ | Overall volatility | 3.10 | |
Ir | Information ratio | -0.26 |
Nu Skin Volatility Alert
Nu Skin Enterprises exhibits very low volatility with skewness of -0.49 and kurtosis of 1.1. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nu Skin's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nu Skin's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Nu Skin Fundamentals Vs Peers
Comparing Nu Skin's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nu Skin's direct or indirect competition across all of the common fundamentals between Nu Skin and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nu Skin or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nu Skin's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nu Skin by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nu Skin to competition |
| Fundamentals | Nu Skin | Peer Average |
| Return On Equity | -0.19 | -0.31 |
| Return On Asset | 0.0378 | -0.14 |
| Profit Margin | (0.08) % | (1.27) % |
| Operating Margin | 0.05 % | (5.51) % |
| Current Valuation | 616.3 M | 16.62 B |
| Shares Outstanding | 49.7 M | 571.82 M |
| Shares Owned By Insiders | 2.29 % | 10.09 % |
| Shares Owned By Institutions | 81.82 % | 39.21 % |
| Number Of Shares Shorted | 1.51 M | 4.71 M |
| Price To Earning | 10.70 X | 28.72 X |
| Price To Book | 0.47 X | 9.51 X |
| Price To Sales | 0.17 X | 11.42 X |
| Revenue | 1.97 B | 9.43 B |
| Gross Profit | 1.59 B | 27.38 B |
| EBITDA | 137.66 M | 3.9 B |
| Net Income | 8.6 M | 570.98 M |
| Cash And Equivalents | 264.73 M | 2.7 B |
| Cash Per Share | 7.69 X | 5.01 X |
| Total Debt | 607.33 M | 5.32 B |
| Debt To Equity | 0.59 % | 48.70 % |
| Current Ratio | 2.30 X | 2.16 X |
| Book Value Per Share | 13.81 X | 1.93 K |
| Cash Flow From Operations | 118.64 M | 971.22 M |
| Short Ratio | 0.95 X | 4.00 X |
| Earnings Per Share | (2.98) X | 3.12 X |
| Price To Earnings To Growth | 2.35 X | 4.89 X |
| Target Price | 9.58 | |
| Number Of Employees | 3.7 K | 18.84 K |
| Beta | 1.13 | -0.15 |
| Market Capitalization | 322.07 M | 19.03 B |
| Total Asset | 1.81 B | 29.47 B |
| Retained Earnings | 1.87 B | 9.33 B |
| Working Capital | 373 M | 1.48 B |
Note: Acquisition by Emma Battle of 4232 shares of Nu Skin subject to Rule 16b-3 [view details]
Nu Skin Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as NUS . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Nu Skin Buy or Sell Advice
When is the right time to buy or sell Nu Skin Enterprises? Buying financial instruments such as NUS Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Nu Skin in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Raw Materials Thematic Idea Now
Raw Materials
Companies that are involved with the development and processing of raw materials such as silver or forestry. The Raw Materials theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Raw Materials Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.